662
Views
12
CrossRef citations to date
0
Altmetric
Editorial

Stereotactic body radiation therapy – A discipline with Nordic origin and profile

&
Pages 564-567 | Published online: 10 May 2012

References

  • Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 1951;102:316–9.
  • Larsson B, Leksell L, Rexed B, Sourander P, Mair W, Andersson B. The high-energy proton beam as a neurosurgical tool. Nature 1958;182:1222–3.
  • Larsson B, Leksell L, Rexed B, Sourander P. Effect of high energy protons on the spinal cord. Acta Radiol 1959;51: 52–64.
  • Lax I, Blomgren H, Naslund I, Svanstrom R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994;33:677–83.
  • Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995;34:861–70.
  • Grau C, Hoyer M, Lindegaard J, Overgaard J. The emerging evidence for Stereotactic Body Radiotherapy. Acta Oncol 2006;45:771–4.
  • Baumann P, Nyman J, Lax I, Friesland S, Hoyer M, Rehn ES, . Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 2006;45:787–95.
  • Zimmermann FB, Geinitz H, Schill S, Thamm R, Nieder C, Schratzenstaller U, . Stereotactic hypofractionated radiotherapy in stage I (T1 - 2 N0 M0) non-small-cell lung cancer (NSCLC). Acta Oncol 2006;45:796–801.
  • Okunieff P, Petersen AL, Philip A, Milano MT, Katz AW, Boros L, . Stereotactic Body Radiation Therapy (SBRT) for lung metastases. Acta Oncol 2006;45:808–17.
  • Kavanagh BD, Schefter TE, Cardenes HR, Stieber VW, Raben D, Timmerman RD, . Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol 2006;45:848–55.
  • Mendez RA, Wunderink W, Hussain SM, de Pooter JA, Heijmen BJ, Nowak PC, . Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study. Acta Oncol 2006;45:831–7.
  • Hoyer M, Roed H, Traberg HA, Ohlhuis L, Petersen J, Nellemann H, . Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 2006;45:823–30.
  • Svedman C, Sandstrom P, Pisa P, Blomgren H, Lax I, Kalkner KM, . A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma. Acta Oncol 2006;45:870–5.
  • Wulf J, Guckenberger M, Haedinger U, Oppitz U, Mueller G, Baier K, . Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 2006;45:838–47.
  • Joyner M, Salter BJ, Papanikolaou N, Fuss M. Stereotactic body radiation therapy for centrally located lung lesions. Acta Oncol 2006;45:802–7.
  • Lock MI, Hoyer M, Bydder SA, Okunieff P, Hahn CA, Vichare A. An international survey on liver metastases radiotherapy. Acta Oncol 2012;51:568–74.
  • Ibarra RA, Rojas D, Snyder L, Yao M, Fabien J, Milano M, . Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors. Acta Oncol 2012;51:575–83.
  • Jhaveri PM, Teh BS, Paulino AC, Blanco AI, Lo SS, Butler EB, . A dose-response relationship for time to bone pain resolution after stereotactic body radiotherapy (SBRT) for renal cell carcinoma (RCC) bony metastases. Acta Oncol 2012;51:584–8.
  • Chang U-K, Cho W-I, Kim M-S, Cho CK, Lee DH, Rhee CH. Local tumor control after retreatment of spinal metastasis using stereotactic body radiotherapy; comparison with initial treatment group. Acta Oncol 2012;51:589–95.
  • Oh D, Ahn YC, Seo JM, Shin EH, Park HC, Lim DH, . Potentially curative stereotactic body radiation therapy (SBRT) for single or oligometastasis to the lung. Acta Oncol 2012;51:596–602.
  • Waldeland E, Ramberg C, Arnesen MR, Helland , Brustugun OT, Malinen E. Dosimetric impact of a frame-based strategy in stereotactic radiotherapy of lung tumors. Acta Oncol 2012;51:603–9.
  • Josipovic M, Persson GF, Logadottir , Smulders B, Westmann G, Bangsgaard JP. Translational and rotational intra- and inter-fractional errors in patient and target position during a short course of frameless stereotactic body radiotherapy. Acta Oncol 2012;51:610–7.
  • Scorsetti M, Alongi F, Filippi AR, Pentimalli S, Navarria P, Clerici E, . Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: A retrospective analysis of 34 patients. Acta Oncol 2012;51:618–23.
  • Onishi H, Ozaki M, Kuriyama K, Komiyama T, Marino K, Araya M, . Serious gastric ulcer event after stereotactic body radiotherapy (SBRT) delivered with concomitant vinorelbine in a patient with left adrenal metastasis of lung cancer Acta Oncol 2012;51:624–8.
  • Garcea G, Lloyd TD, Aylott C, Maddern G, Berry DP. The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours. Eur J Cancer 2003;39:2150–64.
  • Papiez L, Timmerman R, DesRosiers C, Randall M. Extracranial stereotactic radioablation: Physical principles. Acta Oncol 2003;42:882–94.
  • Rassiah-Szegedi P, Salter BJ, Fuller CD, Blough M, Papanikolaou N, Fuss M. Monte Carlo characterization of target doses in stereotactic body radiation therapy (SBRT). Acta Oncol 2006;45:989–94.
  • Lim do H, Yi BY, Mirmiran A, Dhople A, Suntharalingam M, D'Souza WD. Optimal beam arrangement for stereotactic body radiation therapy delivery in lung tumors. Acta Oncol 2010;49:219–24.
  • Wennberg BM, Baumann P, Gagliardi G, Nyman J, Drugge N, Hoyer M, . NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction. Acta Oncol 2011;50:518–27.
  • Scorsetti M, Bignardi M, Alongi F, Fogliata A, Mancosu P, Navarria P, . Stereotactic body radiation therapy for abdominal targets using volumetric intensity modulated arc therapy with RapidArc: Feasibility and clinical preliminary results. Acta Oncol 2011;50:528–38.
  • Nuyttens JJ, Prevost JB, Praag J, Hoogeman M, Van Klaveren RJ, Levendag PC, . Lung tumor tracking during stereotactic radiotherapy treatment with the CyberKnife: Marker placement and early results. Acta Oncol 2006;45:961–5.
  • Slotman BJ, Lagerwaard FJ, Senan S. 4D imaging for target definition in stereotactic radiotherapy for lung cancer. Acta Oncol 2006;45:966–72.
  • Poulsen PR, Cho B, Sawant A, Ruan D, Keall PJ. Dynamic MLC tracking of moving targets with a single kV imager for 3D conformal and IMRT treatments. Acta Oncol 2010;49: 1092–100.
  • Worm ES, Hansen AT, Petersen JB, Muren LP, Praestegaard LH, Hoyer M. Inter- and intrafractional localisation errors in cone-beam CT guided stereotactic radiation therapy of tumours in the liver and lung. Acta Oncol 2010;49:1177–83.
  • Guckenberger M, Meyer J, Wilbert J, Baier K, Mueller G, Wulf J, . Cone-beam CT based image-guidance for extracranial stereotactic radiotherapy of intrapulmonary tumors. Acta Oncol 2006;45:897–906.
  • Purdie TG, Moseley DJ, Bissonnette JP, Sharpe MB, Franks K, Bezjak A, . Respiration correlated cone-beam computed tomography and 4DCT for evaluating target motion in Stereotactic Lung Radiation Therapy. Acta Oncol 2006;45:915–22.
  • Hodge W, Tome WA, Jaradat HA, Orton NP, Khuntia D, Traynor A, . Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation. Acta Oncol 2006;45:890–6.
  • Wurm RE, Gum F, Erbel S, Schlenger L, Scheffler D, Agaoglu D, . Image guided respiratory gated hypofractionated Stereotactic Body Radiation Therapy (H-SBRT) for liver and lung tumors: Initial experience. Acta Oncol 2006;45:881–9.
  • Dawson LA, Eccles C, Craig T. Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol 2006;45: 856–64.
  • Timmerman R, Galvin J, Michalski J, Straube W, Ibbott G, Martin E, . Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer. Acta Oncol 2006;45:779–86.
  • Partridge M, Yamamoto T, Grau C, Høyer M, Muren LP. Imaging of normal lung, liver and parotid gland function for radiotherapy (review). Acta Oncol 2010;47:997–1011.
  • Nyeng TB, Kallehauge JF, Hoyer M, Petersen JB, Poulsen PR, Muren LP. Clinical validation of a 4D-CT based method for lung ventilation measurement in phantoms and patients. Acta Oncol 2011;50:897–907.
  • Palma DA, van Sornsen de Koste JR, Verbakel WF, Senan S. A new approach to quantifying lung damage after stereotactic body radiation therapy. Acta Oncol 2011;50:509–17.
  • Liao Z, Lin SH, Cox JD. Status of particle therapy for lung cancer. Acta Oncol 2011;50:745–56.
  • Petersen JB, Lassen Y, Hansen AT, Muren LP, Grau C, Hoyer M. Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours. Acta Oncol 2011;50:823–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.